Download PDF
Thromb Haemost 1990; 63(01): 148-149
DOI: 10.1055/s-0038-1645708
Letter to the Editor
Schattauer GmbH Stuttgart

Lipids and Warfarin Requirements

A Robinson
Departments of Clinical Biochemistry, Haematology and Clinical Pharmacology, Llandough Hospital, Penarth, S. Glam, UK
,
F O Liau
Departments of Clinical Biochemistry, Haematology and Clinical Pharmacology, Llandough Hospital, Penarth, S. Glam, UK
,
P A Routledge
Departments of Clinical Biochemistry, Haematology and Clinical Pharmacology, Llandough Hospital, Penarth, S. Glam, UK
,
G Backhouse
Departments of Clinical Biochemistry, Haematology and Clinical Pharmacology, Llandough Hospital, Penarth, S. Glam, UK
,
B P Spragg
Departments of Clinical Biochemistry, Haematology and Clinical Pharmacology, Llandough Hospital, Penarth, S. Glam, UK
,
D P Bentley
Departments of Clinical Biochemistry, Haematology and Clinical Pharmacology, Llandough Hospital, Penarth, S. Glam, UK
› Author Affiliations
Further Information

Publication History

Received 25 September 1989

Accepted 01 November 1989

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Nikkila EA, Pelkonen R. Serum lipid-reducing agents and anticoagulant requirements. Lancet 1963; I: 332
    PubMedGoogle Scholar
  • 2 Bentley DP, Backhouse G, Hutchings A, Hadden RL, Spragg B, Routledge PA. Investigation of patients with abnormal response to warfarin. Br J Clin Pharmac 1986; 22: 37-41
    CrossrefPubMedGoogle Scholar
  • 3 Bjornsson TD, Blaschke T, Meffin P. High performance liquid chromatographic analysis of drugs in biological fluids; (1) Warfarin. J Pharmacol Sci 1977; 66: 142-144
    PubMedGoogle Scholar
  • 4 Nikkila EO, Pelkonen R. Serum tocopherol, cholesterol and triglyceride in coronary heart disease. Circulation 1963; 27: 919-928
    CrossrefPubMedGoogle Scholar
  • 5 Mann JI, Lewis B, Shepherd J, Winder AF, Fenster S, Rose L, Margan B. Blood lipid concentrations and other cardiovascular risk factors: distribution prevalence and detection in Britain. Br Med J 1988; 296: 1702-1706
    CrossrefPubMedGoogle Scholar
  • 6 Simpson HC R, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet 1983; i: 786-790
    PubMedGoogle Scholar